Abstract:Bacillus subtilis has been widely used and generally recognized as a safe host for the production of recombinant proteins, high-value chemicals, and pharmaceuticals. Thus, its metabolic engineering attracts significant attention. Nevertheless, the limited availability of selective markers makes this process difficult and time-consuming, especially in the case of multistep biosynthetic pathways. Here, we employ CRISPR/Cas9 technology to build an easy cloning toolkit that addresses commonly encountered obstacles in the metabolic engineering of B. subtilis, including the chromosomal integration locus, promoter, terminator, and guide RNA (gRNA) target. Six promoters were characterized, and the promoter strengths ranged from 0.9- to 23-fold that of the commonly used strong promoter P43. We characterized seven terminators in B. subtilis, and the termination efficiencies (TEs) of the seven terminators are all more than 90%. Six gRNA targets were designed upstream of the promoter and downstream of the terminator. Using a green fluorescent protein (GFP) reporter, we confirmed integration efficiency with the single-locus integration site is up to 100%. We demonstrated the applicability of this toolkit by optimizing the expression of a challenging but industrially important product, lycopene. By heterologous expression of the essential genes for lycopene synthesis on the B. subtilis genome, a total of 13 key genes involved in the lycopene biosynthetic pathway were manipulated. Moreover, our findings showed that the gene cluster ispG-idi-dxs-ispD could positively affect the production of lycopene, while the cluster dxr-ispE-ispF-ispH had a negative effect on lycopene production. Hence, our multilocus integration strategy can facilitate the pathway assembly for production of complex chemicals and pharmaceuticals in B. subtilis. IMPORTANCE We present a toolkit that allows for rapid cloning procedures and one-step subcloning to move from plasmid-based expression to stable chromosome integration and expression in a production strain in less than a week. The utility of the customized tool was demonstrated by integrating the MEP (2C-methyl-d-erythritol-4-phosphate) pathway, part of the pentose phosphate pathway (PPP), and the hetero-lycopene biosynthesis genes by stable expression in the genome. The tool could be useful to engineer B. subtilis strains through diverse recombination events and ultimately improve its potential and scope of industrial application as biological chassis.

Whole‐Cell Biotransformation for the Preparation of Chromopyrrolic Acid and 5,5′‐dichloro‐Chromopyrrolic Acid in Escherichia coli

A Novel Strategy for Whole-Cell Biotransformation Enabling Simultaneous L-Phenyllactic Acid Production and Coenzyme Regeneration.

Improvement of Cephalosporin C Production by Recombinant DNA Integration in Acremonium Chrysogenum

Enantioselective Biosynthesis of l-Phenyllactic Acid by Whole Cells of Recombinant Escherichia coli

Strain-screening in biotransformation of d-pseudoephedrine and expression of its bcdh gene

Construction of Lycopene-Overproducing Saccharomyces Cerevisiae by Combining Directed Evolution and Metabolic Engineering.

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

Co-production of 7-chloro-tryptophan and indole pyruvic acid based on an efficient FAD/FADH2 regeneration system

Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate l-pipecolic acid in Escherichia coli

Enhanced biosynthesis of chiral phenyllactic acid from l-phenylalanine through a new whole-cell biocatalyst

Engineering endogenous l-proline biosynthetic pathway to boost trans-4-hydroxy-l-proline production in Escherichia coli

Environmentally safe production of 7-ACA by recombinant Acremonium chrysogenum

Engineering of Shikimate Pathway and Terminal Branch for Efficient Production of L-Tryptophan in Escherichia coli

Rational design and analysis of an Escherichia coli strain for high-efficiency tryptophan production

Optimization of trans-4-hydroxyproline synthesis pathway by rearrangement center carbon metabolism in Escherichia coli

Efficient production of phenyllactic acid in Escherichia coli via metabolic engineering and fermentation optimization strategies

Chromosome engineering of Escherichia coli for constitutive production of salvianic acid A

Synthesis of enantiopure (S)-6-chlorochroman-4-ol using whole-cell Lactobacillus paracasei biotransformation

Engineering CrtW and CrtZ for improving biosynthesis of astaxanthin in Escherichia coli

Balancing the AspC and AspA Pathways of Escherichia coli by Systematic Metabolic Engineering Strategy for High-Efficient l-Homoserine Production

A Programmable CRISPR/Cas9 Toolkit Improves Lycopene Production in Bacillus subtilis